The 2005 Reform of U.S. Bankruptcy Legislation
Теория и практика общественного развития · 27.05.2026 · (4) · 247-253
DOI: 10.24158/tipor.2026.4.31 ↗Kurz gefasst
Fachartikel in der Zeitschrift Теория и практика общественного развития, online erschienen am 27.05.2026. Verfasst von Artur A. Feroyan.
Abstract (Originalsprache)
This article examines the 2005 reform of U.S. bankruptcy legislation carried out through the adoption of the Bankruptcy Abuse Prevention and Consumer Protection Act of 2005 (BAPCPA It investigates the preconditions for the reform, including the rise in consumer debt and the number of bankruptcy filings (reaching a record high of 2 078 415 in 2005), as well as the long-standing debate between banking industry lobbyists advocating for stronger creditor protections and advocacy organizations advocating for social protections for debtors. This arti-cle analyzes key BAPCPA innovations, such as the introduction of a mandatory means test, the requirement for credit counseling and financial literacy courses, the tightening of repeat bankruptcy rules (increasing the term from 6 to 8 years), the expansion of the list of non-dischargeable liabilities, and increased requirements for debtor attorneys. Particular attention is given to the compromise nature of the reform and its short-term regula-tory effect: a sharp decline in bankruptcies after 2005 (to 617,660 in 2006) followed by an increase due to the “Great Recession” of 2007–2009.
Zitieren
APA
Feroyan, A. A. (2026). The 2005 Reform of U.S. Bankruptcy Legislation. Теория и практика общественного развития, 247-253. https://doi.org/10.24158/tipor.2026.4.31
Vancouver
Feroyan AA. The 2005 Reform of U.S. Bankruptcy Legislation. Теория и практика общественного развития. 2026:247-253. doi:10.24158/tipor.2026.4.31
BibTeX
@article{Feroyan2026,
author = {Feroyan, Artur A.},
title = {The 2005 Reform of U.S. Bankruptcy Legislation},
journal = {Теория и практика общественного развития},
year = {2026},
number = {4},
pages = {247--253},
doi = {10.24158/tipor.2026.4.31}
}
EUVIMED